YAP-mediated DDX3X confers resistance to ferroptosis in breast cancer cells by reducing lipid peroxidation

被引:0
|
作者
Dai, Jia-Zih [1 ,2 ]
Hsu, Wen-Jing [1 ,2 ]
Lin, Mei-Hsiang [3 ]
Shueng, Pei-Wei [4 ,5 ]
Lee, Chi-Ching [6 ,7 ]
Yang, Ching-Chieh [8 ,9 ,10 ]
Lin, Cheng-Wei [1 ,2 ,11 ]
机构
[1] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, 250 Wu Xing St, Taipei 11031, Taiwan
[3] Taipei Med Univ, Coll Pharm, Grad Inst Pharmacognosy, Taipei, Taiwan
[4] Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, New Taipei City, Taiwan
[5] Natl Yang Ming Chiao Tung Univ, Coll Med, Sch Med, Taipei, Taiwan
[6] Istanbul Sabahattin Zaim Univ, Fac Engn & Nat Sci, Dept Food Engn, Istanbul, Turkiye
[7] Klaipeda State Univ Appl Sci, Fac Technol, Dept Food Technol & Nutr, Klaipeda, Lithuania
[8] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan 710, Taiwan
[9] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan
[10] Natl Sun Yat Sen Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[11] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan
关键词
Ferroptosis; DEAD-box helicase 3 X -linked; Glutathione peroxidase 4; Yes-associated protein; Breast cancer; GLUTATHIONE-S-TRANSFERASES; RNA HELICASE DDX3; COLORECTAL-CANCER; SENSITIVITY; MOLECULE; TARGET; DEATH;
D O I
10.1016/j.freeradbiomed.2025.03.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic shifts in cancer cells were found to participate in tumorigenesis, especially driving chemotherapeutic resistance. Ferroptosis is a newly discovered form of cell death induced by excessive accumulations of iron and lipid peroxidation. Susceptibility to ferroptosis can be intrinsically regulated by various cellular metabolic pathways. Therefore, inducing ferroptosis might be a promising anticancer therapeutic strategy. DEAD-box helicase 3 X-linked (DDX3X), a critical modulator of RNA metabolism, was identified as an oncogene in breast cancer and also participates in cancer metabolism and chemotherapeutic resistance. However, the molecular regulation of the association between DDX3X and ferroptosis is largely unknown. Herein, we investigated the correlation between resistance to ferroptosis and DDX3X expression in breast cancer cells. We found that elevation of DDX3X was associated with increased resistance to a ferroptosis inducer in breast cancer cells, and manipulating DDX3X expression regulated the sensitivity to the ferroptosis inducer. Importantly, DDX3X upregulated expression of the anti-ferroptotic enzyme glutathione peroxidase 4 (GPX4) gene to confer ferroptosis resistance in breast cancer cells. Moreover, DDX3X was transcriptionally upregulated by the yes-associated protein (YAP). Knockdown of YAP downregulated DDX3X mRNA expression and facilitated lipid peroxidation, but that were restored in the presence of DDX3X. Clinically, coexpression of DDX3X and YAP was found in a variety of malignancy, and their elevation conferred poor survival prognosis in patients with breast cancer. Together, our findings reveal the crucial role of DDX3X in sensitivity to ferroptosis and underscore its potential as a diagnostic marker and therapeutic target. DDX3X renders resistance to ferroptosis and plays a role in mitigating lipid peroxidation, paving the way for therapeutic vulnerability via targeting cancer metabolism.
引用
收藏
页码:330 / 339
页数:10
相关论文
共 50 条
  • [41] Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
    X Zhang
    X Liu
    J Luo
    W Xiao
    X Ye
    M Chen
    Y Li
    G-J Zhang
    Oncogenesis, 2016, 5 : e269 - e269
  • [42] Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells
    Liu, Bolin
    Ordonez-Ercan, Dalia
    Fan, Zeying
    Edgerton, Susan M.
    Yang, XiaoHe
    Thor, Ann D.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) : 1874 - 1882
  • [43] RANKL Promotes Chemotherapy Resistance in Breast Cancer Cells Through STAT3 Mediated Autophagy Induction
    Tang, Zhen-ning
    Bi, Xiao-fang
    Chen, Wei-liang
    Zhang, Chao-lin
    CLINICAL BREAST CANCER, 2023, 23 (04) : 388 - 396
  • [44] Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin
    S Wang
    X Huang
    C-K Lee
    B Liu
    Oncogene, 2010, 29 : 4225 - 4236
  • [45] Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin
    Wang, S.
    Huang, X.
    Lee, C-K
    Liu, B.
    ONCOGENE, 2010, 29 (29) : 4225 - 4236
  • [46] Notch3 inhibits epithelial-mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
    Zhang, X.
    Liu, X.
    Luo, J.
    Xiao, W.
    Ye, X.
    Chen, M.
    Li, Y.
    Zhang, G-J
    ONCOGENESIS, 2016, 5 : e269 - e269
  • [47] Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
    Fathy Abd-Ellatef, Gamal-Eldein
    Gazzano, Elena
    Chirio, Daniela
    Ragab Hamed, Ahmed
    Belisario, Dimas Carolina
    Zuddas, Carlo
    Peira, Elena
    Rolando, Barbara
    Kopecka, Joanna
    Assem Said Marie, Mohamed
    Sapino, Simona
    Ramadan Fahmy, Sohair
    Gallarate, Marina
    Zaki Abdel-Hamid, Abdel-Hamid
    Riganti, Chiara
    PHARMACEUTICS, 2020, 12 (02)
  • [48] Novel TLR4-Nanog sternness pathway in liver cancer stern cells confers resistance to TGF-β-mediated tumor suppression through YAP1 and IGF2BP3-AKT-mTOR
    Machida, Keigo
    Chen, Chia-Lin
    Kashiwabara, Claudine
    Liu, Jian-Chang
    Feldman, Douglas
    Hyeongnam, Jeong Joseph
    Tsukamoto, Hidekazu
    CANCER RESEARCH, 2011, 71
  • [49] TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway
    Qiao, Jingjing
    Li, Man
    Li, Na
    Xu, Lingzhi
    Huang, Gena
    Yu, Jing
    BIOCHEMICAL GENETICS, 2020, 58 (06) : 953 - 965
  • [50] TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway
    Jingjing Qiao
    Man Li
    Na Li
    Lingzhi Xu
    Gena Huang
    Jing Yu
    Biochemical Genetics, 2020, 58 : 953 - 965